戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 s attached in all eyes before transpupillary thermotherapy.
2 on, plaque radiotherapy, local resection, or thermotherapy.
3 py, and 2 received associated transpupillary thermotherapy.
4 s. 0.4%), PDT (0% vs. 43.8%), transpupillary thermotherapy (0% vs. 0.4%), plaque radiotherapy (7.0% v
5                                These include thermotherapy, 532-nm laser photo-selective vaporization
6                               Transpupillary thermotherapy acts in a subthreshold manner by slightly
7                                              Thermotherapy and chemothermotherapy are the newest foca
8 wn to be a suitable target for laser-induced thermotherapy and enhanced oncolytic viral therapy.
9 l contraction can occur after transpupillary thermotherapy and is a reversible cause of vision loss.
10               In a select group of patients, thermotherapy and laser prostate surgery could be safely
11     In conclusion, melanin as a mediator for thermotherapy and reporter for different imaging modalit
12 es topical therapies, including cryotherapy, thermotherapy and/or intralesional injections with antim
13 days with simultaneous focal therapy (laser, thermotherapy, and brachytherapy) provided at the discre
14 erapy, chemotherapy, laser photocoagulation, thermotherapy, and cryotherapy.
15 ited for drug release, gene delivery, cancer thermotherapy, and energy harvesting.
16 lasia, anti-inflammatory drugs, antibiotics, thermotherapy, and miscellaneous medications.
17 related strongly with failed radiotherapy or thermotherapy before enucleation.
18 small, laser photocoagulation, resection, or thermotherapy can be used.
19   Melphalan SOAC associated with diode laser thermotherapy, cryotherapy, or both at 4-week intervals
20                               In comparison, thermotherapy displays greater patient compliance and le
21 anomas can be controlled with transpupillary thermotherapy, especially those near the optic disk and
22 reatments for 31 patients (86%): diode laser thermotherapy for all of them and cryotherapy or intravi
23 l, vision preservation is satisfactory after thermotherapy for choroidal melanoma, with more than 50%
24 f 6 patients after successful transpupillary thermotherapy for choroidal melanoma.
25                               Transpupillary thermotherapy has recently emerged as a therapeutic opti
26 proton beam radiotherapy, and transpupillary thermotherapy in 85, 11, and 3 eyes, respectively.
27 evaluate the effectiveness of transpupillary thermotherapy in a randomized, double-blind trial.
28 ermotherapy studies regarding the outcome of thermotherapy in LUTS/BPH patients.
29                                        Local thermotherapy is a highly effective, simple, cheap and s
30                               Transpupillary thermotherapy is a recent advancement in the management
31                               Transpupillary thermotherapy is a technique of tumor heating by infrare
32                               Transpupillary thermotherapy is the newest modality used as primary tre
33 , laser photocoagulation, and transpupillary thermotherapy may be used for primary management of this
34 ch as radiofrequency ablation, laser induced thermotherapy, microwave ablation, cryoablation, and ext
35 cluded brachytherapy (n = 2), transpupillary thermotherapy (n = 1), and observation (n = 1).
36 ealed that plaque radiotherapy combined with thermotherapy offers 97% tumor control, similar to charg
37 , laser photocoagulation, and transpupillary thermotherapy or a combination of these methods.
38 ly if the primary therapy was transpupillary thermotherapy or plaque brachytherapy.
39 atment (cryotherapy, laser photocoagulation, thermotherapy, or plaque radiation therapy) during and/o
40 nservative nonenucleation treatments such as thermotherapy, plaque radiotherapy, charged-particle rad
41 frequently observed after minimally invasive thermotherapy procedures aimed at treating benign prosta
42 treatment with brachytherapy, transpupillary thermotherapy, proton beam therapy, laser photocoagulati
43 omacular traction between the transpupillary thermotherapy scar and the macula.
44 ltrasound, brachytherapy, interstitial laser thermotherapy, stereotactic radio surgery, and vascular-
45                       There are a few recent thermotherapy studies regarding the outcome of thermothe
46                Mean time from transpupillary thermotherapy to PPV for treatment of vitreomacular trac
47 que brachytherapy in 5 (16%), transpupillary thermotherapy (TTT) in 18 (56%), and cryotherapy in 24 (
48 eter, and the use of adjuvant transpupillary thermotherapy (TTT).
49 s, and durability of transurethral microwave thermotherapy (TUMT) as a minimal invasive technique.
50 m therapy, brachytherapy, and transpupillary thermotherapy used for recurrences at the tumor margins,
51 solution visual acuity before transpupillary thermotherapy was 0.23 +/- 0.38.
52      Mean visual acuity after transpupillary thermotherapy was 0.53 +/- 0.42.